Eli Lilly said Wednesday its combination antibody therapy "significantly" reduced COVID-19 deaths and hospitalizations in a phase 3 study.
In a study consisting of more than 750 high-risk patients with COVID-19, the company said a combination of bamlanivimab and etesevimab cut the risk of hospitalization and death by 87 percent, Reuters reports.
Daniel Skovronsky, Eli Lilly's chief scientific officer, said the study offers "healthcare providers additional information regarding the use of bamlanivimab and etesevimab together as a potentially life-saving treatment to help those most at risk for severe complications of COVID-19."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
This was the second large study that showed the combination therapy, which was previously authorized by regulators, is effective against mild to moderate COVID-19 cases, though a prior study used a higher dose, Reuters notes. Former FDA commissioner Scott Gottlieb told CNBC this latest data should "push it over the edge in terms of doctors now recognizing that these can provide a benefit."
-
Russian drone tests Romania as Trump spinsSpeed Read Trump is ‘resisting congressional plans to impose newer and tougher penalties on Russia’s energy sector’
-
Trump renews push to fire Cook before Fed meetingSpeed Read The push to remove Cook has ‘quickly become the defining battle in Trump’s effort to take control of the Fed’
-
September 15 editorial cartoonsCartoons Monday’s political cartoons include publisher advice for Kamala Harris, the radicalization pipeline, and flu season guidelines
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
